We are live on ! Find out more
SKYE icon

Skye Bioscience
SKYE

62 hedge funds and large institutions have $196M invested in Skye Bioscience in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

87.27% more ownership

Funds ownership: 0% → 87.27% (+87%)

0% more call options, than puts

Call options by funds: $9K | Put options by funds: $9K

Holders
62
Holders Change
+62
Holders Change %
–
% of All Funds
0.9%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.07%
New
62
Increased
–
Reduced
–
Closed
–
Calls
$9K
Puts
$9K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
5VM
5AM Venture Management
California
+$121M
2
VVM
Versant Venture Management
California
+$23.8M
3
ACM
Altium Capital Management
New York
+$16M
4
LGM
Logos Global Management
California
+$15.4M
5
SFM
Sphera Funds Management
Israel
+$15.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DF
51
Dunhill Financial
United Kingdom
$401 +$593 +50 New
NFSG
52
Newbridge Financial Services Group
Florida
$144 +$214 +18 New
ADL
53
Asset Dedication LLC
California
$129 +$190 +16 New
BCMLT
54
Beacon Capital Management LLC (Tennessee)
Tennessee
$64 +$95 +8 New
CA
55
CoreCap Advisors
Michigan
$64 +$95 +8 New
HI
56
Harbour Investments
Wisconsin
$56 +$83 +7 New
IA
57
IFP Advisors
Florida
$24 +$36 +3 New
PMFA
58
Plante Moran Financial Advisors
Michigan
$24 +$36 +3 New
PS
59
Principal Securities
Iowa
$16 +$24 +2 New
TWC
60
TD Waterhouse Canada
Ontario, Canada
$16 +$24 +2 New
PP
61
PFS Partners
New Jersey
$9 +$12 +1 New
TAM
62
Tucker Asset Management
Colorado
$8 +$12 +1 New
1 2
3

SKYE Hedge Fund Activity: Q2 2024 in Review

62 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q2 2024, worth a combined $196M.

Buyers outnumbered sellers: 62 funds opened new SKYE positions and 0 closed out — a net gain of 62 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was 5AM Venture Management, opening a new position worth an estimated $121M.

  • 62 institutional investors held Skye Bioscience (SKYE) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $196M of Skye Bioscience stock for Q2 2024.
  • 62 funds opened new Skye Bioscience positions in Q2 2024 and 0 closed out, a net change of +62 holders.
  • The largest Skye Bioscience buyer in Q2 2024 was 5AM Venture Management, an estimated $121M added.

Based on aggregated 13F filings for Q2 2024.